-
公开(公告)号:US20190224213A1
公开(公告)日:2019-07-25
申请号:US16318510
申请日:2017-07-20
申请人: CHEMO RESEARCH S.L.
发明人: Enrico COLLI , David F. ARCHER
IPC分类号: A61K31/565 , A61K31/065 , A61K9/02 , A61K9/00 , A61P15/02
摘要: The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 μg to 100 μg estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 μg to 100 μg of vitamin D equivalent.
-
公开(公告)号:US20210069210A1
公开(公告)日:2021-03-11
申请号:US16952142
申请日:2020-11-19
申请人: CHEMO RESEARCH S.L.
发明人: Enrico COLLI , David F. ARCHER
IPC分类号: A61K31/565 , A61K9/02 , A61K47/14 , A61K9/00 , A61K31/59 , A61K31/593 , A61P15/02 , A61K31/065
摘要: The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 μg to 100 μg estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 μg to 100 μg of vitamin D equivalent.
-
公开(公告)号:US20240350415A1
公开(公告)日:2024-10-24
申请号:US18660021
申请日:2024-05-09
申请人: CHEMO RESEARCH, S.L.
发明人: Enrico COLLI
IPC分类号: A61K9/20 , A61K31/567 , A61K47/26 , A61K47/32 , A61P15/18
CPC分类号: A61K9/2054 , A61K31/567 , A61K47/26 , A61K47/32 , A61P15/18
摘要: The invention relates to a new modified release oral pharmaceutical form comprising 17α-cyanomethyl-17-ß-hydroxyestra-4,9-dien-3-one (dienogest) and 17α-ethinylestradiol (ethynyl estradiol), its method of production and its medical and non-medical uses, in particular its use in contraception.
-
公开(公告)号:US20240315959A1
公开(公告)日:2024-09-26
申请号:US18605521
申请日:2024-03-14
申请人: Chemo Research, S.L.
发明人: Enrico COLLI , Carlos DÍEZ FUERTES
IPC分类号: A61K9/00 , A61K31/565 , A61K31/57 , A61K47/32 , A61K47/34
CPC分类号: A61K9/0039 , A61K31/565 , A61K31/57 , A61K47/32 , A61K47/34
摘要: The present invention relates to a method for providing contraception in a female subject, comprising continuous intravaginal administration of levonorgestrel of from about 60 μg/day to about 100 μg/day. The invention further relates to a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and/or dysmenorrhea comprising continuously administering about 60 μg/day to about 160 μg/day of levonorgestrel. Delivery devices, such as, intravaginal rings for putting the methods in practice are also envisaged.
-
公开(公告)号:US20240350515A1
公开(公告)日:2024-10-24
申请号:US18682824
申请日:2022-08-11
申请人: CHEMO RESEARCH, S.L.
发明人: Enrico COLLI , Salustiano PÉREZ
IPC分类号: A61K31/585 , A61K9/20
CPC分类号: A61K31/585 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2054
摘要: The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and/or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.
-
公开(公告)号:US20240315958A1
公开(公告)日:2024-09-26
申请号:US18460441
申请日:2023-09-01
申请人: Chemo Research, S.L.
发明人: Enrico COLLI , Carlos DÍEZ FUERTES
IPC分类号: A61K9/00 , A61K31/565 , A61K31/57 , A61K47/32 , A61K47/34
CPC分类号: A61K9/0039 , A61K31/565 , A61K31/57 , A61K47/32 , A61K47/34
摘要: The present invention relates to a method for providing contraception in a female subject, comprising continuous intravaginal administration of levonorgestrel of from about 60 μg/day to about 100 μg/day. The invention further relates to a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and/or dysmenorrhea comprising continuously administering about 60 μg/day to about 160 μg/day of levonorgestrel. Delivery devices, such as, intravaginal rings for putting the methods in practice are also envisaged.
-
公开(公告)号:US20240041775A1
公开(公告)日:2024-02-08
申请号:US18021165
申请日:2021-08-13
申请人: CHEMO RESEARCH, S.L.
发明人: Enrico COLLI
IPC分类号: A61K9/20 , A61K31/567 , A61K47/26 , A61K47/32 , A61P15/18
CPC分类号: A61K9/2054 , A61K31/567 , A61K47/26 , A61K47/32 , A61P15/18
摘要: The invention relates to a new modified release oral pharmaceutical form comprising 17α-cyanomethyl-17-β-hydrox-yestra-4,9-dien-3-one (dienogest) and 17aα-ethinylestradiol (ethynyl estradiol), its method of production and its medical and non-medical uses, in particular its use in contraception.
-
-
-
-
-
-